Payne Fletcher 4
4 · CATALYST BIOSCIENCES, INC. · Filed Mar 28, 2018
Insider Transaction Report
Form 4
Payne Fletcher
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-03-26$4.63/sh+59$273→ 59 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-03-26−59→ 74,941 totalExercise: $4.63Exp: 2027-07-11→ Common Stock (59 underlying)
Holdings
- 1,668(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Reflects a 1:15 reverse stock split effected on February 10, 2017.
- [F2]The Option vests monthly over a period of four years commencing June 15, 2017.